Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 6, 2007, Pages 546.e1-546.e7

  Denschlag, Dominik ^a   Tan, Leonard ^a   Patel, Samir ^a   Kerim Dikeni, Abbas ^a   Souhami, Luis ^a   Gilbert, Lucy ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

CA 125; endometrial cancer; lymph node dissection; prognosis; stage III

Indexed keywords

ADNEXA DISEASE; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HORMONAL THERAPY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

EID: 34249662707     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.01.018     Document Type: Article

References (30)

1. Jemal A., Murray T., Ward E., et al. Cancer statistics, 2005. CA Cancer J Clin 55 (2005) 10-30
2. Abeler V.M., and Kjorstad K.E. Endometrial adenocarcinoma in Norway: a study of a total population. Cancer 67 (1991) 3093-3103
3. Creasman W.T., Morrow C.P., Bundy B.N., et al. Surgical pathologic spread patterns of endometrial cancer: a gynecologic oncology group study. Cancer 60 suppl (1987) 2035-2041
4. Creasman W.T., and Eddy G.L. Recent advances in endometrial cancer. Semin Surg Oncol 6 (1990) 339-342
5. Partridge E.E., Jessup J.M., Donaldson E.S., et al. 1996 Patient care evaluation study (PCE) of cancer of the corpus uteri, National Cancer Database (NCDB), American College of Surgery. [abstract]. Gynecol Oncol 72 (2005) 445 2005
6. Creasman W.T., Odicino F., Maisonneuve P., et al. Carcinoma of the corpus uteri. Int J Gynaecol Obstet 83 suppl (2003) 79-118
7. Aoki Y., Kase H., Watanabe M., et al. Stage III endometrial cancer: analysis of prognostic factors and failure patterns after adjuvant chemotherapy. Gynecol Oncol 83 (2001) 1-5
8. Gerszten K., Faul C., and Huang Q. Pathologic stage III endometrial cancer treated with adjuvant radiation therapy. Int J Gynecol Cancer 9 (1999) 243-246
9. Greven K.M., Lanciano R.M., Corn B., Case D., and Randall M.E. Pathologic stage III endometrial carcinoma: prognostic factors and patterns of recurrence. Cancer 71 (1993) 3697-3702
10. Schorge J.O., Molpus K.L., Goodman A., Nikrui N., and Fuller Jr. A.F. The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol 63 (1996) 34-39
11. Ulbright T.M., and Roth L.M. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 16 (1985) 28-34
12. Duk J.M., Aalders J.G., Fleuren G.J., and de Bruijn H.W. CA 125: a useful marker in endometrial carcinoma. Am J Obstet Gynecol 155 (1986) 1097-1102
13. Patsner B., Mann W.J., Cohen H., and Loesch M. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma. Am J Obstet Gynecol 158 (1988) 399-402
14. Sood A.K., Buller R.E., Burger R.A., et al. Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome. Obstet Gynecol 90 (1997) 441-447
15. Hsieh C.H., Chang Chien C.C., Lin H., et al. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?. Gynecol Oncol 86 (2002) 28-33
16. Cirisano Jr. F.D., Robboy S.J., Dodge R.K., et al. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma. Gynecol Oncol 77 (2000) 55-65
17. Frumovitz M., Slomovitz B.M., Singh D.K., et al. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J Am Coll Surg 199 (2004) 388-393
18. Frumovitz M., Singh D.K., Meyer L., et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 95 (2004) 463-468
19. Ben-Shachar I., Pavelka J., Cohn D.E., et al. Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet Gynecol 105 (2005) 487-493
20. Roland P.Y., Kelly F.J., Kulwicki C.Y., et al. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment. Gynecol Oncol 93 (2004) 125-130
21. Ayhan A., Taskiran C., Celik C., Aksu T., and Yuce K. Surgical stage III endometrial cancer: analysis of treatment outcomes, prognostic factors and failure patterns. Eur J Gynaecol Oncol 23 (2002) 553-556
22. Schorge J.O., Molpus K.L., Goodman A., Nikrui N., and Fuller Jr. A.F. The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol 63 (1996) 34-39
23. Cragun J.M., Havrilesky L.J., Calingaert B., et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. [see comment]. J Clin Oncol 23 (2005) 3668-3675
24. Kilgore L.C., Partridge E.E., Alvarez R.D., et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 56 (1995) 29-33
25. Onda T., Yoshikawa H., Mizutani K., et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 75 (1997) 1836-1841
26. Katz L.A., Andrews S.J., and Fanning J. Survival after multimodality treatment for stage IIIC endometrial cancer. Am J Obstet Gynecol 184 (2001) 1071-1073
27. Martinez A.A., Weiner S., Podratz K., et al. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation. Gynecol Oncol 90 (2003) 537-546
28. Randall M.E., Filiaci V.L., Muss H., et al. Randomized phase III trial of whole abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study. J Clin Oncol 24 (2006) 36-44
29. Smith M.R., Peters III W.A., and Drescher C.W. Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma. Am J Obstet Gynecol 170 (1994) 1677-1682
30. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA: Cancer J Clin 54 (2004) 8-29